Introduction
In recent years, there has been increasing interest in understanding the biochemical mechanisms involved in the regulation of cell cycle progression. Work conducted in numerous laboratories has suggested that the cell cycle is modulated by the interactions of multiple cell cycle molecules, including cyclins, cyclin activating kinases (CAK's), cyclin dependent kinases (Cdk's) and cyclin dependent kinase inhibitors (Solomon, 1993; Elledge and Harper, 1994; Aprelikova et al., 1995; Hall et al., 1995; Sherr and Roberts, 1995) . Mutations in any of these genes therefore represents a potential pathway of carcinogenesis (Hunter and Pines, 1994; Kamb, 1995) . p27 (or Kip1) is one of the Cdk inhibitors recently cloned (Polyak et al., 1994; Toyoshima and Hunter, 1994) , and is believed to belong to the p21/ WAF1/Cip1 family of universal cyclin kinase inhibitors (Toyoshima et al., 1994; Aprelikova et al., 1995; Hall et al., 1995) . p27 has been shown to inhibit the kinase activity of cyclin A-Cdk2, cyclin B-Cdc2, cyclin D2-Cdk4 and cyclin E-Cdk2, by preventing Cdk activation, and thereby precluding cells from entering S-phase (Polyak et al., 1994; Toyoshima and Hunter, 1994) . One approach to the study of the biology of p27, its eect on the cell cycle, and potential for gene therapy applications is the use of p27 expression vectors. To this end, we have constructed a recombinant adenovirus expressing human p27 (Adp27) and studied its eects on the cell cycle. We chose adenoviral vectors because they can be rendered replication-incompetent (by deleting E1 sequences), can be grown to high titers, and can infect many diverse cancer epithelial cell types with nearly 100% eciency (Jones and Shenk, 1979; Seth et al., 1986; Ginsberg, 1988; Graham and Prevec, 1991; Katayose et al., 1995a,b) . In this report, we describe the construction of Adp27, a replication-de®cient adenovirus which expresses p27, and show that adenovirus mediated p27 expression in human breast cancer cells inhibits cell cycle progression, and is associated with the loss of Cdk2 and Cdc2 kinase activity. Moreover, we have also found that when compared to another recently described adenoviral vector, AdWAF1 (Katayose et al., 1995b) , Adp27 was more cytotoxic, and caused greater G 1 /S arrest and loss of cyclin kinase activity at a lower moi (multiplicity of infection) than AdWAF1. Based on these ®ndings, we conclude that p27 plays a potential role in growth regulation, and that Adp27 may be useful in the further study of cell growth regulation, and may be a better candidate than WAF1/Cip1 for gene therapy of tumors.
Results

Adp27-mediated p27 expression
Adp27-mediated p27 expression was examined following infection of MDA-MB-231 and MCF-7 human breast cancer cells with Adp27. Western blot analyses demonstrated that the level of p27 increased substantially following infection with Adp27 at 100 p.f.u. (plaque forming unit) per cell in each cell line ( Figure  1a ). Adp27-mediated p27 levels increased in MDA-MB-231 cells with rising doses of Adp27 (in the range of 1 ± 100 p.f.u./cell, Figure 1b 
p27 expression induces cell cycle arrest
In order to verify that the exogenous protein expressed by Adp27 was functional, we investigated the dose- (Figures 2 and  3 ). These results demonstrate that infection of cells with Adp27 leads to a marked loss of S-phase, and clearly indicate the functionality of Adp27-expressed p27 protein.
Adp27 is more cytotoxic than AdWAF1
The marked eects of Adp27 infection on the cell cycle prompted a comparison between p27 and the related p21/WAF1/Cip1, another member of the universal cyclin kinase inhibitor family (Toyoshima and Hunter, 1994; Aprelikova et al., 1995; Hall et al., 1995) . The adenoviral vector AdWAF1, which expresses p21/WAF1/Cip1 (described in Katayose et al., 1995b) , was used to perform cytotoxicity assays, as described in Materials and methods. The ratios of the IC 50 's of Adp27 and AdWAF1 in multiple cell lines are shown in Table 1 . Adp27 was up to 56 times more cytotoxic than AdWAF1. In contrast to previous ®ndings with an adenovirus expressing p53 (AdWTp53) (Katayose et al., 1995a) , this relationship was found to be independent of endogenous p53 status.
Adp27 causes G 1 /S arrest at a lower moi than AdWAF1
Due to the greater cytotoxicity displayed by Adp27, we investigated the biochemical mechanisms by which Adp27 exerts its control on the cell cycle and compared these eects with those of AdWAF1. In particular, we examined the induction of G 1 /S arrest and inhibition of the cyclin kinases responsible for cell cycle arrest, and compared the relative abilities of both Adp27 and AdWAF1.
The data shown in Figures 4 and 5 are from a typical experiment and demonstrate that infection of MDA-MB-231 cells by Adp27 resulted in G 1 /S arrest at a lower moi than AdWAF1. Examination of the DNA histograms in Figure 4 shows an increase in the number of cells in G 1 and a decrease in the number of cells in S-phase at 24 h following infection with Adp27 at 1 p.f.u./cell. In contrast, infection with 10 p.f.u./cell of AdWAF1 was required to achieve a comparable cell cycle arrest. The relative percent distribution of cells in G 1 and S-phase for each Figure 5a and b respectively. Infection with AdControl did not noticeably alter the distribution of cells.
Adp27 decreases Cdk2 and cyclin B1-Cdc2 activities at a lower moi than AdWAF1
Since Cdk2 and Cdc2 are important cell cycle regulators (Solomon et al., 1993; Elledge and Harper, 1994; Aprelikova et al., 1995; Hall et al., 1995; Sherr and Roberts, 1995) , we compared the eects of Adp27, AdWAF1, and AdControl infection on these kinases.
As shown in Figure 6 , infection of MDA-MB-231 cells with Adp27 at the lowest dose (1 p.f.u./cell) resulted in a slight decrease in the kinase activities of both Cdk2 and cyclin B1-Cdc2. Higher doses of Adp27 resulted in the complete loss of both kinase activities. In contrast, 10 p.f.u./cell of AdWAF1 were required for any loss of kinase activity for both Cdk2 and Cdc2. Infection with a control adenovirus did not cause any change in these enzyme activities at a dose of 200 p.f.u./cell. These results indicate that overexpression of p27 is associated with a marked decrease in Cdk2 and cyclin B1-Cdc2 kinase activities, which can lead to G 1 cell cycle arrest. These eects are seen at a lower moi for Adp27 than for AdWAF1.
Discussion
In this report we show that infection of human breast cancer cells with Adp27, a recombinant adenovirus expressing p27
Kip1
, resulted in high levels of p27 expression. This marked increase in p27 levels led to Lukas et al. (1995) ; and G 1 cell cycle arrest and decreased Cdk2 and cyclin B1-Cdc2 activities. Importantly, these eects were seen at a relatively low moi when compared with another adenovirus vector expressing the related universal cyclin kinase inhibitor, AdWAF1. This relationhip was seen in both the cell cycle data and the kinase data, although the two assays displayed dierences in sensitivity (a higher dose was required for both viruses to see loss of kinase activity than to see cell cycle arrest). Because the adenoviral vectors Adp27 and AdWAF1 dier only in their respective cDNA sequences, there should be no dierences in either the levels of transgene expression or of the infectivity of the recombinant virus particles. Therefore, any dierences in cytotoxicity, induction of cell cycle arrest, or loss of kinase activity should be directly due to the eects of the expressed transgene. These ®ndings suggest that Adp27 may be a useful vector to Effects of adenovirus expressing p27
Kip1 C Craig et al study cell growth regulation, and for gene therapy purposes where the inhibition of cell growth is desired. Cyclin kinase inhibitors which block cell cycle progression, in vitro and in vivo, at G 1 phase and therefore induce cytotoxicity in tumor cells (El-Deiry et al., 1993; Harber et al., 1993; Xiong et al., 1993; Gottesman, 1994) have been previously indicated as potentially useful for cancer gene therapy (Hunter and Pines, 1994; Gottesman, 1994; Kamb, 1995; Katayose et al., 1995b; Yang et al., 1995) . Based on these results, we believe that p27 represents a good candidate for cancer gene therapy, and perhaps may be better than WAF1/Cip1. Moreover, Adp27 may also be used in combined gene therapy/chemotherapy strategies where growth arrested cells could be induced to undergo apoptosis by other means. Another unique future of p27 is that in some contexts it has been shown to be regulated by TGF-b (Polyak et al., 1994; Reynisdottir et al., 1995) . Although this paper does not address the eects of p27 on apoptosis nor the eects of TGF-b on p27 expression, one future goal will be to evaluate whether p27 alone or in combination with other agents (such as TGF-b) can have an in¯uence on the apoptotic pathway and hence have other therapeutic applications. Since Adp27 is replication-incompetent, can be grown to high titers, and can enter cells by an ecient receptor-mediated endocytosis pathway, it represents an attractive vector for gene therapy (Jones and Shenk, 1979; Seth et al., 1986; Ginsberg, 1988; Graham and Prevec, 1991; Katayose et al., 1995a,b) . Future experiments will be directed toward evaluating the in vivo eects of Adp27 in comparison with AdWAF1 and Adp53.
Materials and methods
Construction of recombinant adenovirus vectors
Adp27 was constructed by cotransfection of the shuttle vector pCC1 containing the p27 expression cassette and pJM17 plasmid DNA by methods previously described (Katayose et al., 1995a,b) . The plasmid pJM17 contains the adenovirus type 5 genome of 9.24 mu-100 mu. The shuttle vector pCC1 was constructed by inserting the human p27 expression cassette (10.3 mu) into a null shuttle vector, by methods described previously (Katayose et al., 1995a,b) . The shuttle vector pCC1 contains the left inverted terminal repeat (ITR), origin of replication, encapsidation signals, and E1a enhancer derived from adenovirus type 5; human cytomegalovirus (CMV) immediate early promoter; a 1.5 kilobase fragment of human wild-type p27 cDNA (Polyak et al., 1994) ; and SV40 RNA maturation signal. The two DNA's were cotransfected into the adenovirus transformed human embryonic kidney cell line 293 (ATCC CRL1573) by calcium phosphate mediated gene transfer technique, (Gibco BRL, Gaithersburg, MD). Several adenoviral plaques were screened for the presence of p27 sequences by polymerase chain reactions (PCR) using a set of primers which were 5'-TGG ACC ACG AAG AGT TAA CC and 3'-TTT CTG ACT AGG CAG CCT GT. A viral plaque containing p27 cDNA but devoid of E1 sequences was used to infect 293 cells. Adp27 was subsequently puri®ed by double CsCl 2 gradient as described previously (Katayose et al., 1995a,b) . To screen against the presence of revertant, replication competent adenoviruses, a viral protein synthesis assay was performed in MCF-7 cells, as previously described (Seth et al., 1984) . AdWAF1 has been described recently (Katayose et al., 1995b) . AdControl is the adenovirus vector dl312 which contains no insert and is replication/transformation de®cient (Jones and Shenk, 1979 ; kindly provided by T Shenk, Princeton, NJ). To control for variation between virus preparations, multiple preparations of each virus were used.
Cell culture
MCF-7 (kindly provided by R Buick, University of Toronto, Toronto, Ontario, Canada), MDA-MB-231 (ATCC HTB26), and BT-549 (ATCC HTB122) breast cancer cells; U-2 OS (ATCC HTB96) and Saos-2 (ATCC HTB85) osteosarcomas; H358 lung cancer cells (kindly provided by J Minna, University of Texas, Dallas, Texas); and 293 (ATCC CRL1573) adenovirus-transformed human embryonic kidney cells, were cultured in Improved Minimal Essential Medium (Gibco GRL, Gaithersburg, MD) containing 10% fetal bovine serum (FBS) as described previously (Katayose et al., 1995a,b) .
Cytotoxicity assays
Cells were plated in triplicate in 96-well dishes (500 cells/ well) and incubated for 24 h at 378C. Cells were then exposed to varying concentrations of Adp27, AdWAF1, and AdControl, and incubated for 7 days at 378C. A colorimetric assay was performed as described previously (Skehan et al., 1990) . Brie¯y, cells were ®xed in 10% trichloroacetic acid for 1 h, washed ®ve times with water and allowed to air dry. Cells were then stained for 10 min with 0.4% sulphorhodamine B (Sigma, St Louis, MO) dissolved in 1% acetic acid, and rinsed ®ve times with 1% acetic acid. An A 564 was obtained using a BioKinetics Reader EL340 (Bio-Tek Instruments), which was used as a measure of cell number. The IC 50 (median toxic viral doses) was calculated assuming the survival rate of uninfected cells to be 100%. Fold dierences in IC 50 's were calculated by dividing the IC 50 of AdWAF1 by the IC 50 of Adp27 in each cell line.
Western blot analysis
Cells (1610 6 ) were plated in 10 cm dishes and incubated with adenovirus vectors for 24 h. Cells were then scraped and cell lysates subjected to Western blot analysis as previously described (Katayose et al., 1995a,b) . Blots were probed with 3 mg/ml of Ab-2 for p27 or with 3 mg/ml of anti-actin (Ab-1) antibody. All antibodies were obtained from Oncogene Science (Uniondale, NY). Blots were washed with phosphate buered saline (PBS) containing 0.1% Tween 20, incubated with horse radish peroxidase conjugated to secondary antibody and speci®c complex detected by the enhanced chemiluminescence technique according to manufacturer's directions (Amersham, Arlington Heights, IL).
Cell cycle analysis
Cells were plated in 6-well dishes (2610 5 cells/well) and infected with adenoviral vectors (1 ± 10 p.f.u./cell) for 24 h. Cells were harvested by trypsinization and resuspended at a concentration of 4610 5 cells/ml in 100% FBS and stored frozen until analysed. Samples were stained for DNA cell cycle analysis using the previously described procedure (Katayose et al., 1995b) . DNA content was measured using a FACScan¯ow cytometer (Becton-Dickinson, Mountain View, CA). Cell cycle analysis of the resulting DNA histograms of cell number versus integrated red fluorescence was performed with Multicycle (Phoenix Flow Systems, San Diego, CA) using a zero order polynomial to model the S-phase fraction. Debris, cell aggregates, and G 0 /G 1 doublets were removed from the cell cycle analysis by software algorithms (Kopp and Wersto, 1992; Wersto and Stetler-Stevenson, 1995) .
BrdU incorporation
Cells (4610 6 ) were plated in 15 cm dishes and infected with adenoviral vectors (1 ± 200 p.f.u./cell) and incubated at 378C for 24 h. Cells were then pulsed with 10 mM 5-bromodeoxyuridine (BrdU; Sigma Chemical Co., St Louis, MO) for 30 min in IMEM containing 10% FBS. The cells were then harvested by trypsinization, washed, ®xed in cold 70% ethanol, and stored at 7208C. For bivariate analysis of BrdU incorporation across the cell cycle, ®xed cells were pelleted, and treated with pepsin (Boehringer Mannheim Inc., Indianapolis, IN; 0.4 mg/ml in 0.1 M HCl) for 30 min at room temperature, as previously described (Schutte et al., 1987) . After washing in PBT buer (PBS containing bovine serum albumin (BSA) 1 mg/ml, 0.05% Tween-20, pH 7.4) to terminate the enzymatic treatment, cells were resuspended in 2 M HCl and incubated for 30 min at 378C. Cells were washed with borax buer (0.1 M sodium tetraborate, pH 8.5), followed by PBT buer, and incubated with a¯uorescein-labeled monoclonal antibody to BrdU (Becton Dickinson Immunocytometry Systems, San Jose, CA) for 45 min. Labeled cells were washed in PBT buer and resuspended in PBS containing 10 mg/ml propidium iodide (Calbiochem-Behring, Inc., San Diego, CA) for 15 min prior to¯ow cytometric analysis. Cells were analysed with a FACScan¯ow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA) using doublet discrimination (peak height vs integrated signals).
Immune complex kinase assays
Cells (4610 6 ) were plated in 15 cm dishes. Cells were infected with increasing doses (1 ± 100 p.f.u./cell) of recombinant adenoviruses for 24 h. Cells were then harvested and lysed with buer containing 40 mM Tris-Cl (pH 8.0), 120 mM NaCl and 0.5% NP40 (TNN buer). For Cdk2 activity, lysates were immunoprecipitated with antiCdk2 antibody (Santa Cruz), and for cyclin B1-Cdc2 with anti-cyclin B1 (Santa Cruz). In brief, cell lysates were incubated with 1 mg primary antibody for 1 h at 48C. Immune complexes were collected on protein A-Sepharose beads. The beads were washed three times with TNN buer and three times with kinase reaction buer (20 mM TrisHCl pH 7.5, 4 mM MgCl 2 ). The beads were then resuspended in kinase assay mixture containing 2 mCi [ 32 P]ATP and histone H1 (2 mg) (Gibco BRL) as the substrate. After incubation at 378C the reaction was stopped by the addition of 26Laemli SDS sample buer (0.125 M Tris-Cl, pH 6.8; 4% SDS; 10% b-mercaptoethanol, and 20% glycerol). Proteins were separated by electrophoresis in 10% SDS-polyacrylamide gels. Gels were dried and then autoradiographed.
Abbreviations
Ad, adenovirus; WT, wild type; moi, multiplicity of infection; pfu, plaque forming unit; BrdU, 5-bromodeoxyuridine; FBS, fetal bovine serum; PBS, phosphate buered saline.
